Testing effectiveness (Phase 2)Ended earlyNCT00009919
What this trial is testing
SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment
Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 50